Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
SpringTide Ventures is an early-stage venture capital firm founded in the United States, with offices in Boston, Salt Lake City, and San Francisco. Established to support healthcare companies, the firm focuses on financing innovative health-tech startups that aim to improve human health and wellness. As of April 2024, SpringTide Ventures has closed its Fund II at $65 million, contributing to a total AUM exceeding $100 million.
The firm has built a portfolio of eight companies, emphasizing early-stage financing in sectors such as digital health, medical devices, and life sciences. SpringTide Ventures is committed to enhancing patient care and improving healthcare outcomes through technology. The firm actively engages with its portfolio companies, leveraging extensive healthcare networks and partnerships to facilitate impactful innovations.
SpringTide Ventures specializes in early-stage investments in healthcare companies, particularly within the health-tech sector. Their investment strategy emphasizes innovative solutions that address significant healthcare challenges, including reproductive medicine, telehealth, chronic disease management, and mental health care. The firm typically invests at the pre-seed, seed, and seed-plus stages, with check sizes estimated between $500,000 and $5 million.
SpringTide Ventures seeks founders who are developing technologies that can significantly improve healthcare delivery and outcomes. The firm values products that demonstrate a measurable impact on healthcare workflows and outcomes, navigating regulatory and provider realities effectively. Their geographic focus is primarily on the United States, although they have some exposure to Israel and Europe.
SpringTide Ventures has a diverse portfolio of eight companies, each addressing unique challenges within the healthcare sector. Notable portfolio companies include:
Austin Walters: Co-founder & Managing Partner. Austin has extensive experience in healthcare venture capital and leads the firm’s investment strategy, focusing on improving patient care and outcomes.
Ryan Morley: Partner. Ryan brings a wealth of knowledge in health-tech investments and is actively involved in sourcing and managing portfolio companies.
Brad Otto: Partner. Recently appointed in 2024, Brad supports the firm’s expansion efforts and focuses on identifying promising health-tech startups.
Claire Smith: Partner. Claire joined SpringTide Ventures in 2024 and contributes to the firm’s investment strategy and portfolio management.
Whitney Taylor: Project Manager. Whitney plays a key role in managing projects and supporting portfolio companies in their growth initiatives.
Josh Cowdin: Chief Financial Officer. Josh has a background in finance and investment management, previously serving as the founding CEO of Belltower Fund Group.
Gabi Tellez: Associate. Gabi supports the investment team in sourcing deals and conducting due diligence on potential investments.
To pitch SpringTide Ventures, founders should visit their website at springtide.com. It is advisable to include a clear explanation of how the product addresses significant healthcare challenges and improves patient outcomes. Founders should also be prepared to discuss their business model and market strategy.
While specific response time expectations are not disclosed, it is recommended to follow up if no response is received within a reasonable timeframe. Warm introductions through mutual connections in the healthcare sector may enhance the chances of securing a meeting.
In April 2024, SpringTide Ventures announced the close of its Fund II at $65 million, contributing to a total AUM exceeding $100 million. This fund will continue to support early-stage healthcare companies, particularly in the health-tech sector.
Notable portfolio company PathologyWatch was acquired by Sonic Healthcare for $150 million, highlighting the firm's successful investment strategy in the healthcare space. Additionally, SpringTide Ventures has been actively involved in supporting its portfolio companies through various funding rounds, including Tava Health's recent $20 million raise.
What are SpringTide Ventures' investment criteria?
SpringTide Ventures focuses on early-stage healthcare companies, particularly in the health-tech sector. They look for innovative solutions that address significant healthcare challenges and improve patient outcomes.
How can I pitch to SpringTide Ventures?
Founders can pitch SpringTide Ventures through their website at springtide.com. It is recommended to include details about how your product improves healthcare delivery and outcomes.
What makes SpringTide Ventures different from other VCs?
SpringTide Ventures emphasizes a founder-first approach, focusing on health-tech innovations that have a direct impact on healthcare systems. They leverage extensive healthcare networks to support their portfolio companies.
What is the geographic scope of SpringTide Ventures?
The firm primarily invests in the United States but has some exposure to international markets, including Israel and Europe.
What is the typical check size for investments?
SpringTide Ventures typically invests between $500,000 and $5 million across pre-seed, seed, and seed-plus stages.
What kind of post-investment support does SpringTide Ventures provide?
SpringTide Ventures adds value through its extensive healthcare networks, facilitating connections with healthcare providers, policymakers, and system leaders to enhance the potential for impactful healthcare innovations.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.